Features RSS

International Immigration Law Practice: A View from Hong Kong, the Gateway to China

Eugene Chow - Chow King & Associates

Eugene Chow

The recent global economic crisis in many regions of the world has provided an opportunity for China by boosting its role in Asia and in the world economy at large. As the US, the EU and rest of the world gradually recovers from the crisis, China continues its trajectory of spectacular economic growth.

Roundtable: Mergers & Acquisitions 2010

Who's Who Legal hosts a discussion between four leading merger and acquisition lawyers that appears in The International Who's Who of Merger & Acquisition Lawyers.

Emerging Markets Could Rule 2010 After Year of Strategic M&A in Developed World

Charles Martin

Charles Martin

The year 2009 began with a sharp decline in M&A activity, a hangover from the end of 2008 as the world concentrated on the fallout from the collapse of Lehman Brothers and on rescuing the global financial system.

The Outlook for 2010: M&A Still in Disarray as Credit Crunch Cloud Lingers

Maximilian Schiessl - Hengeler Mueller

Maximilian Schiessl

After an M&A boom which took global deal volumes to record highs in 2006 and 2007, the financial crisis has hit M&A markets extremely hard. While 2009 was a good year for investors in the stock markets and many other markets, M&A activity was very negatively affected by the credit crunch its various consequences.

Roundtable: Life Sciences

The International Who’s Who of Life Sciences Lawyers has brought together five of the leading practitioners in the world to discuss key issues facing lawyers today.

Pharmaceutical Pricing and Reimbursement in Canada: An Overview for Innovative Drug Manufacturers

Penny S Bonner - Ogilvy Renault LLP

Jill M Daley - Ogilvy Renault LLP

Penny Bonner

The pricing and reimbursement of innovative pharmaceuticals in Canada is controlled at three levels: by the federal Patented Medicine Prices Review Board, by the 17 federal, provincial and territorial public drug plans and by the Common Drug Review. This system means that an innovative manufacturer must obtain the approval of 19 different bodies for the price of a new drug in Canada.

The Supplementary Protection Certificate for Medicinal Products: An Update

Carla Schoonderbeek - NautaDutilh

Carla Schoonderbeek

Since its introduction in 1992 the Supplementary Protection Certificate (SPC) has been the object of litigation in many jurisdictions. The case law has been able to clarify the use of the regulations establishing the SPC, but some issues still have not been resolved.

Roundtable: Aviation

The International Who’s Who of Aviation Lawyers has brought together four of the world’s leading practitioners to discuss key issues facing lawyers today.

Back to top

Follow us on LinkedIn

News & Features

Community News

Analysis

Features

Pro Bono

Corporate Counsel

Women in Law

Future Leaders

Research Reports

Practice Areas

Firms

The Who's Who Legal 100

Awards

Special Reports

Events

Shop

About Us

Research Schedule

It is not possible to buy entry into any Who's Who Legal publication

Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.

Copyright © 2018 Law Business Research Ltd. All rights reserved. | http://www.lbresearch.com

87 Lancaster Road, London, W11 1QQ, UK | Tel: +44 20 7908 1180 / Fax: +44 207 229 6910

http://www.whoswholegal.com | editorial@whoswholegal.com

Law Business Research Ltd

87 Lancaster Road, London
W11 1QQ, UK